FDA Inspection 1182041 — South Florida Institute For Reproductive Medicine, P.A.

South Florida Institute For Reproductive Medicine, P.A. — FEI 3003926766

The FDA completed an inspection of South Florida Institute For Reproductive Medicine, P.A. on Oct 19, 2022 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 19, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
South Miami, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.